BioHarvest Sciences Inc (NAS:BHST)

Q2 2026 BioHarvest Sciences Inc Earnings Call Transcript

Aug 11, 2026 / 12:00 PM GMT

Release Date Price: $2.08 (-1.19%)

Transcript

Key Points

Positve

BioHarvest Sciences Inc (BHST) secured its first-ever CDMO manufacturing and supply agreement for a rare fragrance, with a 20-ton commitment potentially generating $20-30 million in revenue in 2027-2028.
The company's CDMO division is making significant progress, including completing Stage 1 of a saffron development program and advancing to a $1.125 million Stage 2 agreement, with BioHarvest retaining a 25% ownership stake.
BioHarvest Sciences Inc (BHST) received a $1.4 million grant from the Israel Innovation Authority to integrate AI and machine learning into its plant cell culture workflows, supporting future growth without dilution.
The company is strategically focusing on high-value CDMO opportunities, which is expected to significantly reduce the full-year EBITDA loss from $4-5 million to $1.5-2.5 million.
BioHarvest Sciences Inc (BHST) has a strong cash position of $16.2 million as of June 30, 2026, and aims to avoid equity-based funding, with a clear path to EBITDA breakeven in 2027.
The company is implementing offensive moves in its D2C business, including a 20% price increase for new subscribers and the launch of Single Dose Vinya Daily Chews in September, which are expected to improve conversion rates and lower acquisition costs.

Negative

BioHarvest Sciences Inc (BHST) revised its full-year revenue guidance downward to $37-40 million from $42-48 million, reflecting a reallocation of spend and a more conservative outlook.
The direct-to-consumer business is now expected to report an EBITDA loss of $1.5-2.5 million, a reversal from the previous guidance of a gain of $0.5-2 million.
The company faces significant media inflation, with Meta media costs increasing double-digits, which has pressured customer acquisition costs and led to a strategic pullback in spending.
The fragrance contract involves no upfront payments, and revenue recognition will be delayed until the first half of 2027, with modest initial production capacity.
The company's net loss for Q2 2026 was $3.7 million, and adjusted EBITDA loss widened to $1.6 million from $1.2 million year-over-year, indicating ongoing operational challenges.
BioHarvest Sciences Inc (BHST) is keeping the fragrance customer and product details confidential, which may limit investor visibility and create uncertainty about the contract's full potential.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

8MV0.MU - Bioharvest Sciences Inc
Q2 2026 BioHarvest Sciences Inc Earnings Call
Aug 11, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to the Bioharvest Sciences Second Quarter 2026 Financial Results Conference Call.

As a reminder, all participants are in listen-only mode.

A question-and-answer session will follow the formal presentation.

If you would like to ask a question, please press *1 on your phone.

To withdraw your question. Please press *1 again.

As a reminder, this conference is being recorded.

I will now hand the call over to Dori Kurowski of LifeSci Advisors.

Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.